Several PAD4 inhibitors, such as F-amidine, Cl-amidine, o-F-amidine, o-Cl-amidine and TDFA, have been developed to block PAD4-mediated signaling in both cancer and infection contexts [134,135]. This evidence concerns the gene PADI4 and cancer.